A retrospective study of CSF and serum analysis from a total of 43 patients with sarcoidosis, 20 with systemic lupus ery-
with neurological involvement found local synthesis of oligoclonal IgG using isoelectric focusing and immunoblotting in 51%, 25%, and 8% respectively at some stage in their disease. Blood-brain barrier breakdown, when assessed with an albumin ratio found 47% of patients with sarcoidosis, 30% of those with systemic lupus erythematosus, and 42% of patients with BehVet's disease exhibiting abnormal barrier function at some time. Serial CSF analysis showed that clinical relapses were associated with worsening barrier function and in some patients the development of local oligoclonal IgG synthesis; conversely steroid treatment led to a statistically significant improvement in barrier function, and in two patients a loss of oligoclonal IgG bands.
A higher proportion of patients had MRI abnormalities than oligoclonal IgG or blood-brain barrier breakdown, MRI Ever since abnormalities of CSF, particularly with respect to immunoglobulin G (IgG), were first described by Kabat et al in the 1940s in various neurological conditions,' the range of neurological disorders associated with these abnormalities has been the subject of much study. [2] [3] [4] [5] The presence of what is thought to be locally synthesised IgG within the intrathecal compartment has been shown both quantitatively, and qualitatively with the description of oligoclonal banding of the IgG. The association of local synthesis of IgG, both quantitative and qualitative, with multiple sclerosis and infections of the nervous system has now been well established in many studies, but there is no such consensus on the inflammatory disorders, especially sarcoidosis and the connective tissue disorders when there is neurological involvement.
The neurological presentation of these disorders may be similar and can lead to great diagnostic difficulty in differentiating them from multiple sclerosis, especially when the neurological manifestations may be the first sign of the disease, as happens in about 5% of patients with sarcoidosis. 6 Any laboratory investigation that can distinguish between the disorders would therefor be of great benefit, particularly in view of the potential for treatment of the inflammatory disorders. It has been reported that sarcoidosis is noted for the absence of local synthesis of oligoclonal IgG, and this has been suggested as a possible distinguishing feature. 8 We have thus sought to define the incidence of CSF abnormalities in these inflammatory disorders by a retrospective analysis of all the definite cases referred to our laboratory for routine CSF analysis.
Magnetic resonance imaging has been shown to be of value in patients with inflammatory diseases of the CNS, particularly sarcoidosis. 9 We have also sought to compare MRI data with the CSF data to examine the association between abnormalities found by the techniques, and to compare the sensitivities of the analyses. Free light chain analysis The presence of free light chains was assessed by polyacrylamide gel electrophoresis of CSF, and kappa and lambda light chain immunoblotting was performed as previously described. 17 Briefly, CSF specimens were electrophoresed on 120 x 6 mm rod polyacrylamide gels for two hours with a uniform amount of protein (100 ng) loaded on each gel. Protein was transferred from the rod gels by compression on to nitrocellulose membranes, which were then incubated with type-specific goat antihuman antiserum and finally rabbit antigoat IgG-horse radish peroxidase conjugate before visualising with 3-amino 4-ethyl carbazole. Free light chains were assessed by counting the number of bands seen outside the heavy chain region on the gel immunoblots (and thus unbound); each band was assumed to represent a different B lymphocyte clone.
Materials and methods

PATIENTS
MRI SCANS
Patients were studied on a 0 5 T MRI scanner provided by the Multiple Sclerosis Society of Great Britain and Northern Ireland.
Consecutive five or 10 mm axial slices of the whole brain were obtained with a moderately T2 weighted sequence (E2000/60). The size of brain lesions was quantified by a technique previously described.'8 The lesions were divided into two subgroups according to their anatomical location: either contiguous with or separate from CSF containing spaces (subarachnoid spaces or the ventricular system). The sum of the lesion sizes was used to assess the total bulk of lesions in each location.
Results
CSF ANALYSIS
Sarcoidosis A total of 69 CSF and serum pairs from 43 patients were analysed. Tables 2 and 3 detail the isoelectric focusing and blood-brain barrier function results respectively for the individual CSF and serum pairs. All samples had isoelectric focusing performed, and 25 out of 69 (36%) had local synthesis of oligoclonal IgG. One of the 69 CSF samples was insufficient for albumin ratio analysis, which was abnormal in 38 of the remaining 68 (55%) CSF and serum pairs. When there was local synthesis of oligcFclonal IgG the bloodbrain barrier abnormality tended to be mild; absence of local synthesis was associated with more severe blood-brain barrier damage; however, there was no overall correlation between blood-brain barrier state and the presence of local synthesis of oligoclonal IgG. Tables 2 and 3 also show the most abnormal responses that each individual patient recorded. In only one patient was there insufficient CSF for albumin analysis. Twenty of the 42 (48%) patients had abnormal blood-brain barrier function at some time (representing 47% of the total number of patients), and 22 of the 43 (51 %) patients had local synthesis of oligoclonal IgG. In most patients with more than one CSF and serum pair analysis, the most abnormal blood-brain barrier function coincided with the most abnormal isoelectric focusing result. Ten In total 16 CSF and serum pairs from nine patients had both normal isoelectric focusing and albumin ratios.
Systemic lupus erythematosus A total of 25 CSF and serum pairs from 20 patients were analysed. Tables 2 and 3 show the individual paired results, with two pairs having insufficient CSF for the albumin ratio. Six of the 23 (26%) samples had abnormal blood-brain barrier function (representing 24% of all sample pairs), and seven out of 25 (28%) had local synthesis of oligoclonal IgG. None of six samples with local synthesis had abnormal blood-brain barrier function; six of 17 samples with no local synthesis had abnormal blood-brain barrier function. The relation between blood-brain barrier state and local synthesis of oligoclonal IgG was similar to sarcoidosis, with local synthesis associated with little or no impairment of the bloodbrain barrier and more severe impairment with the absence of local synthesis. Tables 2 and 3 
Only three patients had a free light chain response. With such small numbers, no overall comment can be made as to any relation with disease activity. Four patients with systemic lupus erythematosus had a normal CSF and serum analysis by isoelectric focusing and albumin ratio.
Behcet's disease Fourteen CSF and serum pairs from 12 patients with Behcet's disease were analysed (tables 2 and 3). Five out of 13 pairs, or five out of 12 patients, had abnormal blood-brain barrier function. Only two out of 14 pairs, or one out of 12 patients had local synthesis ofIgG.
Two patients had two CSF and serum pairs analysed (data not shown). In one patient, steroid treatment resulted in an improvement of blood-brain barrier function and a reduction in the white blood cell count, but no alteration in the isoelectric focusing pattern. In the other the initial CSF was normal, but only oligoclonal band and free light chain analyses were performed on the second CSF, which remained normal despite disease progression requiring treatment.
No patient produced a free light chain response in the CSF, and six patients had a normal albumin ratio and isoelectric focusing analysis.
CSF CHANGES IN RESPONSE TO TREATMENT
Combining the results for the effect of steroids and immunosuppressants on the CSF variables studied in all three groups of patients, there was a statistically significant association between the introduction of such drugs and an improvement in blood-brain barrier function when assessed by the albumin ratio (Fisher's exact test; P = 0-05) a reduction in CSF total protein (Fisher's exact test; P = 0-018), and an improvement in CSF white blood cell count (Fisher's exact test, P = 0-0 18). There was no significant association with changes on isoelectric focusing.
MAGNETIC RESONANCE IMAGING Table 4 gives a summary of the results of MRI scanning with respect to the presence or absence of abnormalities and the correlation Table 4 Comparison ofMRI results in all three groups ofdiseases with isoelectric focusing result and blood-brain barrierfunction assessed by the albumin ratio. Sixteen patients had quantitative MRI analysis performed. Thirteen were abnormal, 12 of the 16 had lesions "contiguous with CSF", 10 had lesions "separate from CSF", nine had both "contiguous" and "separate" lesions, three "contiguous" lesions only, and one "separate" lesions only.
There was no statistical association between the site of the lesions on MRI and the presence of local synthesis of IgG or blood-brain barrier function, or between total volume of abnormality on MRI and degree of blood-brain barrier impairment assessed by the albumin ratio. The exclusion of patients with MRI and CSF analysis more than six weeks apart or with MRI performed later than the CSF analysis improved the statistical associations but these did not quite achieve significance. It should be noted that 10 patients had a myelopathy as part of their disease, and in five this was the only neurological disturbance. Five patients with myelopathy had brain MRI, three with myelopathy alone, and all were positive on MRI. Two of the three patients with negative MRI had optic neuropathies.
Systemic lupus erythematosus
Only four patients underwent MRI, of which three were abnormal. Two of these three had local synthesis of IgG, and all had abnormal blood-brain barrier function.
There was no statistical association between MRI findings and local synthesis of IgG or blood-brain barrier function.
Beh,et's disease Nine patients underwent MRI examinations, and all had quantitative analyses. Seven of the nine patients had abnormal MRI. Only one of the nine had local synthesis of IgG, and five had abnormal blood-brain barrier function. Of the seven abnormal on MRI, only one had local synthesis of IgG, and five had abnormal blood-brain barrier function.
Six patients had "separate" lesions, three had "contiguous" abnormalities, two had abnormalities ofboth contiguous and separate nature, one contiguous only and four separate only.
There was no statistical association between site or volume of lesions and local synthesis of IgG or blood-brain barrier functions.
Effect of interval between lumbar puncture and MRI on result concordance A comparison of the interval between lumbar puncture and MRI for each diagnostic group, and agreement (both abnormal or normal) or disagreement (one normal, the other abnormal) in the results was performed. Overall, in all three disease groups, there was no statistical association between result agreement or disagreement and the MRI examination taking place before or after the lumbar puncture. When sarcoidosis alone was considered, there was a significant association between MRI being performed after the lumbar puncture, and disagreement in the results of isoelectric focusing (Fishers exact test, P = 0-049), but not blood-brain barrier function. In the other two disease groups taken individually, there were no statistical associations found, but numbers were small. Discussion A review of the medical literature to date concerning the presence of intrathecally synthesised IgG in the three disorders with neurological involvement has yielded information on only 10 patients with Behqet's disease, 42 patients with systemic lupus erythematosus, and 53 patients with sarcoidosis (table 5) . 19 36 Most studies have used agarose electrophoresis for the detection of oligoclonal IgG, with only a few using polyacrylamide gel isoelectric focusing, one study using PAGE, and only one other study using agarose isoelectric focusing as we have. A variety of quantitative methods were also employed, predominantly the IgG index, although the reference ranges for the upper limit of normal varied from 0-58 to 0-83. Many patients underwent examination by several methods, but the study by Yahr et a12 did not specify the total numbers studied. Overall, local synthesis of oligoclonal IgG was found by any method in five out of nine patients with BehSet's disease, 16 out of 42 (38%) patients with systemic lupus erythematosus, and five out of 23 (22%) patients with sarcoidosis.
With quantitative methods, overall the one patient (out of an uncertain number) studied with Behcet's disease, 10 out of 37 (27%) patients with systemic lupus erythematosus, and 18 out of 48 (38%) patients with sarcoidosis (including the one patient reported by Yahr et a12) had intrathecal synthesis of IgG.
In our study, all patients underwent agarose isoelectric focusing with specific immunofixation for IgG, and most had calculation of an albumin ratio for determination of blood-brain barrier function.
We have found that 51% of patients with sarcoidosis have local synthesis of oligoclonal IgG, a figure more than double the proportion found in reported series, and 25% of patients with systemic lupus erythematosus have local synthesis of oligoclonal IgG, which is lower than that reported. Only 8% of patients with Behcet's disease in our study had local synthesis of oligoclonal IgG, but our 12 cases must be considered more representative than the total of 10 from the medical literature. The differences with the reported series may be due to the uniformity of the methods of analysis applied to our patients, and the small numbers of patients reported by most authors. Steroids or immunosuppressants considerably reduced the permeability of the bloodbrain barrier, reflecting a "tightening up" of the blood-brain barrier, and clinical relapses saw an increased impairment in blood-brain barrier function. In some patients the improvement in blood-brain barrier function with treatment saw the appearance of local synthesis of oligoclonal IgG. Whether this represents an unmasking of the CSF bands by the removal of serum polyclonal IgG is difficult to prove conclusively, but it is the most likely explanation, and may again explain some of the published differences. The improvement in blood-brain barrier function must contribute to the clinical effects of immunomodulating agents irrespective of any effect that they may have on the primary disease process as evidenced in this study by the loss of oligoclonal IgG and changes in free light chains and white blood cell counts in some patients. This changing response of oligoclonal IgG may be useful diagnostically, in that patients with multiple sclerosis never lose their oligoclonal response, which remains constant over long periods. As the differential diagnosis often lies between multiple sclerosis and these disorders, such a change would suggest that multiple sclerosis is less likely, but further studies are required with larger patient numbers to assess how reliable this is.
Magnetic resonance imaging consistently yielded a greater proportion of patients with abnormalities in all three groups in this study. Great caution must be exercised, however, when comparing analyses performed at differing times in these diseases where neurological damage is a dynamic and intermittent process. As we have shown, in our patients with sarcoidosis MRI was more likely to produce a result differing from isoelectric focusing of IgG when it was performed later than the lumber puncture. This indicates that the reason for the better performance of MRI in this group may be due in part to temporal factors in the study, rather than to a greatly increased sensitivity. Two other factors may account for the discrepant MRI and CSF findings. Firstly, old MRI was nonenhanced-it is not possible on such a scan to distinguish old, inactive gliotic regions from active inflammatory or granulomatous regions. One could anticipate the second making the more important contribution to CSF abnormalities. Future studies should include gadolinium-DPTA enhanced MRI, as this agent can cross an abnormal blood-brain barrier and thus identify active inflammatory/ granulomatous lesions. Secondly, MRI of the spinal cord was not performed-it is possible that disease activity at this level contributes to the CSF abnormalities in some cases. Such considerations must therefore be borne in mind when examining retrospective studies of comparisons between MRI and CSF analysis in other diseases, notably multiple sclerosis. Furthermore, the appearances on unenhanced MRI of multiple sclerosis, systemic lupus erythematosus, sarcoidosis and Behget's disease may be indistinguishable;938 in such a setting, the serial examination of CSF may help to clarify the diagnosis. Magnetic resonance imaging and CSF data may thus be regarded as complementary. There are other CSF variables that may be important in inflammatory disorders that were not examined here, such as cytokines and mononuclear cell populations, and comparisons of these with MRI may yield more fruitful results, but they were not within the scope of this study given its retrospective nature.
Our study reaffirms that local synthesis of oligoclonal IgG is a feature of sarcoidosis and systemic lupus erythematosus, and is uncommon in Behget's disease when there is neurological involvement, and as such cannot be used to distinguish them from multiple sclerosis or other demyelinating disorders. The presence of a changing oligoclonal IgG response with clinical state and with treatment in a few patients needs further study. The nature of the antigen(s) exciting local synthesis of oligoclonal IgG is unknown, but the changing response to treatment implies that the antigen(s) are transitory, and may perhaps be "self' antigens revealed by destructive processes, as has been suggested for multiple sclerosis. Blood-brain barrier function is also impaired during active disease in most patients, and this impairment, which parallels clinical severity, can be modulated by immunosuppressive agents. 
